A Novel Strategy to Enhance Microfracture Treatment With Stromal Cell-Derived Factor-1 in a Rat Model

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Microfracture is a common articular cartilage repair technique.
• Fibrocartilage formation limits microfracture's long-term success.
• Stromal cell-derived factor-1 (SDF-1) attracts mesenchymal stem cells (MSCs) and promotes chondrogenesis.

Purpose of the Study:

• Confirm SDF-1's chemoattractant properties in vitro.
• Develop an in vivo method for SDF-1 incorporation into scaffolds.
• Enhance cartilage repair in a rat osteochondral defect model.

Main Methods:

• Harvested and cultured rat bone marrow-derived MSCs.
• Assessed MSC migration in vitro using CFDA-SE labeling.
• Created rat osteochondral defects and implanted collagen scaffolds with or without SDF-1.
• Evaluated cartilage repair histologically using Safranin O/Fast Green staining and Modified O'Driscoll scores.

Main Results:

• SDF-1 demonstrated a dose-dependent chemotactic effect on MSCs, with optimal activity between 10-100 ng/ml.
• SDF-1 treated defects showed complete filling with mature, proteoglycan-rich cartilage.
• Significant improvement in cartilage repair scores was observed in the SDF-1 group compared to controls at 8 weeks.

Conclusions:

• A simple method for incorporating SDF-1 into collagen scaffolds was developed.
• SDF-1 effectively enhances MSC recruitment and promotes hyaline cartilage regeneration.
• SDF-1 mediated signaling shows significant potential for improving cartilage defect repair quality.